TSG‐6 is weakly chondroprotective in murine OA but does not account for FGF2‐mediated joint protection

TSG‐6 is weakly chondroprotective in murine OA but does not account for FGF2‐mediated joint protection

Objective Tumor necrosis factor α–stimulated gene 6 (TSG‐6) is an anti‐inflammatory protein highly expressed in osteoarthritis (OA), but its influence on the course of OA is unknown. Methods Cartilage injury was assessed by murine hip avulsion or by recutting rested explants. Forty‐two previously v...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Zhu, L, Donhou, S, Burleigh, A, Miotla Zarebska, J, Curtinha, M, Parisi, I, Khan, SN, Dell'Accio, F, Chanalaris, A, Vincent, TL
Format:	Journal article
Sprache:	English
Veröffentlicht:	Wiley 2020

Ähnliche Einträge

TSG‐6 Is Weakly Chondroprotective in Murine OA but Does not Account for FGF2‐Mediated Joint Protection
von: Linyi Zhu, et al.
Veröffentlicht: (2020-10-01)

A chondroprotective role for matrix-bound FGF2
von: Chia, S, et al.
Veröffentlicht: (2009)

Pathogenic protease expression in murine OA is critically dependent upon mechanical joint loading
von: Burleigh, A, et al.
Veröffentlicht: (2012)

Does pain at an earlier stage of chondropathy protect female mice from structural progression after surgically induced osteoarthritis?
von: von Loga, IS, et al.
Veröffentlicht: (2020)

Joint surface defects: clinical course and cellular response in spontaneous and experimental lesions
von: F Dell’accio, et al.
Veröffentlicht: (2010-09-01)

Inferiority of LABORAS over incapacitance testing to measure spontaneous murine osteoarthritis pain
von: von Loga, IS, et al.
Veröffentlicht: (2019)

CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy
von: Miotla Zarebska, J, et al.
Veröffentlicht: (2016)

Interleukin 13 (IL-13)-regulated expression of the chondroprotective metalloproteinase ADAM15 is reduced in aging cartilage
von: C.Y. Yang, et al.
Veröffentlicht: (2020-12-01)

Joint surface defects: clinical course and cellular response in spontaneous and experimental lesions.
von: Dell'accio, F, et al.
Veröffentlicht: (2010)

Understanding tissue response to cartilage injury
von: Dell'accio, F, et al.
Veröffentlicht: (2010)

Ros-responsive nanocomposite scaffolds for sustained releasing puerarin to achieve chondroprotection in OA rats
von: Depeng Fang, et al.
Veröffentlicht: (2023-09-01)

MECHANICAL LOAD DRIVES INFLAMMATORY GENE EXPRESSION AND DISEASE IN MURINE OA
von: Burleigh, A, et al.
Veröffentlicht: (2010)

Accelerated disease in a surgical model of murine OA in mice lacking FGF-2
von: Chia, S, et al.
Veröffentlicht: (2007)

Interleukin 13 (IL-13)-regulated expression of the chondroprotective metalloproteinase ADAM15 is reduced in aging cartilage
von: Yang, CY, et al.
Veröffentlicht: (2020)

Regulation of nerve growth factor in the articular cartilage causes pain in murine OA
von: Driscoll, C, et al.
Veröffentlicht: (2014)

ADAMTS4 and ADAMTS5 are upregulated early in the DMM model of murine OA
von: Burleigh, A, et al.
Veröffentlicht: (2009)

Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis.
von: Chia, S, et al.
Veröffentlicht: (2009)

CARTILAGE INJURY REGULATES NERVE GROWTH FACTOR (NGF) IN VTTRO AND IN VIVO AND DRIVES PAINFUL BEHAVIOUR IN MURINE OA
von: Driscoll, C, et al.
Veröffentlicht: (2014)

IL18 IS SECRETED UPON JOINT INJURY AND IS A KEY PATHOGENIC CYTOKINE IN MURINE OSTEOARTHRITIS
von: Vincent, T, et al.
Veröffentlicht: (2014)

Comparison of LABORAS with static incapacitance testing for assessing spontaneous pain behaviour in surgically-induced murine osteoarthritis
von: von Loga, IS, et al.
Veröffentlicht: (2020)

Erratum to “Ros-responsive nanocomposite scaffolds for sustained releasing puerarin to achieve chondroprotection in OA rats” [Mater. Des. 233 (2023) 112214]
von: Depeng Fang, et al.
Veröffentlicht: (2024-08-01)

Fibroblast growth factor 2 promotes regeneration of cartilage by attracting mesenchymal stem cells to the site of cartilage injury
von: Khan, S, et al.
Veröffentlicht: (2018)

Differential inflammatory gene expression patterns in JNK2 knockout mice in response to IL1, cartilage injury and surgically induced osteoarthritis
von: Ismail, HM, et al.
Veröffentlicht: (2016)

The recombinant Link module of human TSG-6 suppresses cartilage damage in models of osteoarthritis: a potential disease-modifying OA drug
von: Drummond, SP, et al.
Veröffentlicht: (2023)

Perspectives of chondroprotective therapy of osteoarthritis
von: L L Alekseeva
Veröffentlicht: (2003-08-01)

The role of biomechanical factors in OA development
von: Burleigh, A, et al.
Veröffentlicht: (2010)

Suramin inhibits osteoarthritic cartilage degradation by increasing extracellular levels of chondroprotective tissue inhibitor of metalloproteinases 3 (TIMP-3)
von: Chanalaris, A, et al.
Veröffentlicht: (2017)

Fibromodulin and tenascin N are potential biomarkers of post-traumatic OA
von: Papadopoulou, A, et al.
Veröffentlicht: (2014)

Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis.
von: Qurratul-Ain Dar, et al.
Veröffentlicht: (2017-01-01)

Dexamethasone: chondroprotective corticosteroid or catabolic killer?
von: Black, Robert Xavier, et al.
Veröffentlicht: (2020)

CHONDROPROTECTIVE DRUG ALFLUTOP IN THE TREATMENT OF OSTEOARTHRITIS
von: G V Lukina, et al.
Veröffentlicht: (2001-04-01)

Evidence base of pharmaconutraceuticals with chondroprotective action
von: O. A. Shavlovskaya, et al.
Veröffentlicht: (2024-04-01)

Dexamethasone: chondroprotective corticosteroid or catabolic killer?
von: R Black, et al.
Veröffentlicht: (2019-11-01)

Chondroprotective effect of rebamipide on articular cartilage
von: Yoshiaki Suzuki, et al.
Veröffentlicht: (2016-10-01)

Anti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model
von: Tuo Jingsheng, et al.
Veröffentlicht: (2012-03-01)

Persistent global inflammation caused by the loss of SIRT1 protects against experimental osteoarthritis
von: Sacitharan, P, et al.
Veröffentlicht: (2017)

Creation of an activin A conditional knockout mouse for OA research
von: Jin, H, et al.
Veröffentlicht: (2014)

Chondroprotective factors in osteoarthritis: A joint affair
von: Mimpen, J, et al.
Veröffentlicht: (2019)

The effectiveness of chondroprotective therapy in patients with lumbosacral dorsopathies
von: N. V. Yakovleva, et al.
Veröffentlicht: (2021-06-01)

Chondroprotection and Molecular Mechanism of Action of Phytonutraceuticals on Osteoarthritis
von: Stanislav Sukhikh, et al.
Veröffentlicht: (2021-04-01)